iBio, Inc. — Income Charts
62 quarters of history · ending 2025-12-31 · SEC EDGAR
Revenue↓-100.0% -$200K
$0
Cost of Revenue↓-92.0% -$172K
$15K
Gross Profit↓-84.9% -$258K
$46K
R&D↑+128.0% +$2M
$4M
D&A↑+15.6% +$19K
$141K
Operating Income↓-113.7% -$5M
$-9M
EBITDA↓-116.5% -$5M
$-9M
Interest Expense↓-28.1% -$16K
$41K
Pretax Income
$383K
Tax Provision
$0
Net Income↓-106.1% -$5M
$-9M
Gross Margin↑+69.7pts
105.3%
Operating Margin
-5951.0%
Net Margin
-5720.0%